Nelly R. Mugo - Revision history

WikiModEn2: Wikify.

2022-07-08T15:36:26Z

Wikify.

← Older revision		Revision as of 15:36, 8 July 2022
Line 13:		Line 13:
	* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}		* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}

	Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the {{UNI\|University of Washington\|UW}} (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both [[HIV]] and cervical cancer prevention.		Nelly Mugo has a joint appointment at the [https://www.kemri.go.ke/ Kenya Medical Research Institute] (KEMRI) and the {{UNI\|University of Washington\|UW}} (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both [[HIV]] and cervical cancer prevention.

	She leads a clinical trial site in Thika, Kenya that has conducted high impact [[HIV]] prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for [[HIV]] prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on [[HIV]] self-testing to reduce frequency of clinic visits for oral PrEP users.		She leads a clinical trial site in Thika, Kenya that has conducted high impact [[HIV]] prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for [[HIV]] prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on [[HIV]] self-testing to reduce frequency of clinic visits for oral PrEP users.

WikiAdmin: using UNI template

2021-12-05T12:59:22Z

using UNI template

← Older revision		Revision as of 12:59, 5 December 2021
Line 10:		Line 10:

	<blockquote>'''Mugo, Nelly R.'''		<blockquote>'''Mugo, Nelly R.'''
	* The Kenya Medical Research Institute (KEMRI), Kenya; University of Washington, Department of Global Health, USA		* The Kenya Medical Research Institute (KEMRI), Kenya; {{UNI\|University of Washington\|UW}}, Department of Global Health, USA
	* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}		* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}

	Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both [[HIV]] and cervical cancer prevention.		Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the {{UNI\|University of Washington\|UW}} (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both [[HIV]] and cervical cancer prevention.

	She leads a clinical trial site in Thika, Kenya that has conducted high impact [[HIV]] prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for [[HIV]] prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on [[HIV]] self-testing to reduce frequency of clinic visits for oral PrEP users.		She leads a clinical trial site in Thika, Kenya that has conducted high impact [[HIV]] prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for [[HIV]] prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on [[HIV]] self-testing to reduce frequency of clinic visits for oral PrEP users.

WikiAdmin: wikify HIV

2021-11-24T13:59:56Z

wikify HIV

WikiAdmin: using Template:MBChB

2021-10-13T15:37:58Z

using Template:MBChB

← Older revision		Revision as of 15:37, 13 October 2021
Line 11:		Line 11:
	<blockquote>'''Mugo, Nelly R.'''		<blockquote>'''Mugo, Nelly R.'''
	* The Kenya Medical Research Institute (KEMRI), Kenya; University of Washington, Department of Global Health, USA		* The Kenya Medical Research Institute (KEMRI), Kenya; University of Washington, Department of Global Health, USA
	* ~~MBCHb~~ ({{MD}}), MMed (Obs/Gyn), {{MPH}}		* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}

	Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both HIV and cervical cancer prevention.		Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both HIV and cervical cancer prevention.

WikiAdmin: using ABBR section

2021-10-13T13:07:50Z

using ABBR section

← Older revision		Revision as of 13:07, 13 October 2021
Line 31:		Line 31:
	PubMed lists Dr. Mugo as a named author of 108 papers on various subjects. A number of the papers relate to HIV infection, especially in woman and as partners of HIV+ males. There is no clear indication of her position on male circumcision.		PubMed lists Dr. Mugo as a named author of 108 papers on various subjects. A number of the papers relate to HIV infection, especially in woman and as partners of HIV+ males. There is no clear indication of her position on male circumcision.

			{{ABBR}}
	{{REF}}		{{REF}}

WikiAdmin: using Template:MD; using Template:MPH

2021-06-14T14:10:43Z

using Template:MD; using Template:MPH

← Older revision		Revision as of 14:10, 14 June 2021
Line 11:		Line 11:
	<blockquote>'''Mugo, Nelly R.'''		<blockquote>'''Mugo, Nelly R.'''
	* The Kenya Medical Research Institute (KEMRI), Kenya; University of Washington, Department of Global Health, USA		* The Kenya Medical Research Institute (KEMRI), Kenya; University of Washington, Department of Global Health, USA
	* MBCHb (MD), MMed (Obs/Gyn), MPH		* MBCHb ({{MD}}), MMed (Obs/Gyn), {{MPH}}

	Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both HIV and cervical cancer prevention.		Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both HIV and cervical cancer prevention.

WikiModEn2: Add text.

2020-04-03T13:30:41Z

Add text.

← Older revision		Revision as of 13:30, 3 April 2020
Line 28:		Line 28:
	}}</ref>		}}</ref>
	</blockquote>		</blockquote>

			PubMed lists Dr. Mugo as a named author of 108 papers on various subjects. A number of the papers relate to HIV infection, especially in woman and as partners of HIV+ males. There is no clear indication of her position on male circumcision.

	{{REF}}		{{REF}}

WikiAdmin at 14:21, 28 March 2020

2020-03-28T14:21:41Z

← Older revision		Revision as of 14:21, 28 March 2020
Line 32:		Line 32:

	{{DEFAULTSORT:Mugo, Nelly R.}}		{{DEFAULTSORT:Mugo, Nelly R.}}

			[[Category:Person]]
			[[Category:Female]]

			[[Category:WHO]]

	[[Category:Africa]]		[[Category:Africa]]
	[[Category:Kenya]]		[[Category:Kenya]]
	~~[[Category:WHO]]~~

	~~[[Category:Female]]~~
	~~[[Category:People]]~~

	[[de:{{FULLPAGENAME}}]]		[[de:{{FULLPAGENAME}}]]

WikiAdmin at 19:09, 26 March 2020

2020-03-26T19:09:55Z

← Older revision		Revision as of 19:09, 26 March 2020
Line 35:		Line 35:
	[[Category:Africa]]		[[Category:Africa]]
	[[Category:Kenya]]		[[Category:Kenya]]
			[[Category:WHO]]

			[[Category:Female]]
	[[Category:People]]		[[Category:People]]
	~~[[Category:WHO]]~~

	[[de:{{FULLPAGENAME}}]]		[[de:{{FULLPAGENAME}}]]

WikiAdmin: add DEFAULTSORT

2020-03-26T09:52:26Z

add DEFAULTSORT

← Older revision		Revision as of 09:52, 26 March 2020
Line 19:		Line 19:
	She participated in the development of the Kenya HIV Prevention Revolution Road Map and led the writing of the HIV PrEP section of the Kenya 2016 ART guidelines. Dr. Mugo is currently a member of the Kenya PrEP technical working group and the reproductive cancer technical working group.		She participated in the development of the Kenya HIV Prevention Revolution Road Map and led the writing of the HIV PrEP section of the Kenya 2016 ART guidelines. Dr. Mugo is currently a member of the Kenya PrEP technical working group and the reproductive cancer technical working group.

	Dr. Mugo co-chaired the WHO Guidelines Committee for Couples HIV Testing and Counseling and Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples in 2011, the 2012 World Health Organization and Stakeholders’ Technical Consultation on Hormonal Contraception and HIV, the WHO Guidelines Advisory Committee for PrEP for Prevention in 2015. She has been a member of the International Partnership for Microbicides (IPM), Safety Evaluation Committee Meeting providing oversight for the Ring study. She is well published and has presented in multiple global forum on the topic of HIV prevention.		Dr. Mugo co-chaired the WHO Guidelines Committee for Couples HIV Testing and Counseling and Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples in 2011, the 2012 World Health Organization and Stakeholders’ Technical Consultation on Hormonal Contraception and HIV, the WHO Guidelines Advisory Committee for PrEP for Prevention in 2015. She has been a member of the International Partnership for Microbicides (IPM), Safety Evaluation Committee Meeting providing oversight for the Ring study. She is well published and has presented in multiple global forum on the topic of HIV prevention.<ref>{{REFdocument
	<ref>{{REFdocument
	\|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1		\|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1
	\|title=Biographies of Guideline Development Group (GDG) members for WHO guidance		\|title=Biographies of Guideline Development Group (GDG) members for WHO guidance
Line 31:		Line 30:

	{{REF}}		{{REF}}

			{{DEFAULTSORT:Mugo, Nelly R.}}

	[[Category:Africa]]		[[Category:Africa]]

← Older revision		Revision as of 13:59, 24 November 2021
Line 1:		Line 1:
	'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.<ref>{{REFweb		'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for [[HIV]] prevention and related service delivery for adolescent boys and men in generalized [[HIV]] epidemics.<ref>{{REFweb
	\|url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/		\|url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/
	\|title=WHO to develop new guidelines on male circumcision		\|title=WHO to develop new guidelines on male circumcision
Line 13:		Line 13:
	* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}		* {{MBChB}} ({{MD}}), MMed (Obs/Gyn), {{MPH}}

	Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both HIV and cervical cancer prevention.		Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both [[HIV]] and cervical cancer prevention.

	She leads a clinical trial site in Thika, Kenya that has conducted high impact HIV prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for HIV prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on HIV self-testing to reduce frequency of clinic visits for oral PrEP users.		She leads a clinical trial site in Thika, Kenya that has conducted high impact [[HIV]] prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for [[HIV]] prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on [[HIV]] self-testing to reduce frequency of clinic visits for oral PrEP users.

	She participated in the development of the Kenya HIV Prevention Revolution Road Map and led the writing of the HIV PrEP section of the Kenya 2016 ART guidelines. Dr. Mugo is currently a member of the Kenya PrEP technical working group and the reproductive cancer technical working group.		She participated in the development of the Kenya [[HIV]] Prevention Revolution Road Map and led the writing of the [[HIV]] PrEP section of the Kenya 2016 ART guidelines. Dr. Mugo is currently a member of the Kenya PrEP technical working group and the reproductive cancer technical working group.

	Dr. Mugo co-chaired the WHO Guidelines Committee for Couples HIV Testing and Counseling and Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples in 2011, the 2012 World Health Organization and Stakeholders’ Technical Consultation on Hormonal Contraception and HIV, the WHO Guidelines Advisory Committee for PrEP for Prevention in 2015. She has been a member of the International Partnership for Microbicides (IPM), Safety Evaluation Committee Meeting providing oversight for the Ring study. She is well published and has presented in multiple global forum on the topic of HIV prevention.<ref>{{REFdocument		Dr. Mugo co-chaired the WHO Guidelines Committee for Couples [[HIV]] Testing and Counseling and Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples in 2011, the 2012 World Health Organization and Stakeholders’ Technical Consultation on Hormonal Contraception and [[HIV]], the WHO Guidelines Advisory Committee for PrEP for Prevention in 2015. She has been a member of the International Partnership for Microbicides (IPM), Safety Evaluation Committee Meeting providing oversight for the Ring study. She is well published and has presented in multiple global forum on the topic of [[HIV]] prevention.<ref>{{REFdocument
	\|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1		\|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1
	\|title=Biographies of Guideline Development Group (GDG) members for WHO guidance		\|title=Biographies of Guideline Development Group (GDG) members for WHO guidance
Line 29:		Line 29:
	</blockquote>		</blockquote>

	PubMed lists Dr. Mugo as a named author of 108 papers on various subjects. A number of the papers relate to HIV infection, especially in woman and as partners of HIV+ males. There is no clear indication of her position on male circumcision.		PubMed lists Dr. Mugo as a named author of 108 papers on various subjects. A number of the papers relate to [[HIV]] infection, especially in woman and as partners of [[HIV]]+ males. There is no clear indication of her position on male circumcision.

	{{ABBR}}		{{ABBR}}